BMJ 1994;308:1015-1017 (16 April)
Papers
Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3
D W G Brown,
M E B Ramsay,
A F Richards,
E Miller
Enteric and Respiratory Virus Division, Virus Reference Division, PHLS Central Public Health Laboratory, London NW9 5HT Immunisation Division, PHLS Communicable Disease Surveillance Centre, London NW9 5EQ Correspondence and requests for reprints to: Dr Miller.
Abstract
Objectives : To validate a method for salivary diagnosis of measles and to assess the diagnostic accuracy of notified cases of measles. Design - Blood and saliva samples were collected within 90 days of onset of symptoms from patients clinically diagnosed as having measles and tested for specific IgM by antibody capture radiommunoassay.
Setting : 17 districts in England and one in southern Ireland during August 1991 to February 1993.
Subjects : 236 children and adults with measles notified by a general practitioner.
Results : Specific IgM was detected in serum in only 85 (36%) of the 236 cases. In cases associated with outbreaks and tested within six weeks of onset, 53/57 (93%) of samples were IgM positive, thereby confirming the sensitivity of serum IgM detection as a marker of recent infection. The serological confirmation rate was lower in cases with a documented history of vaccination (13/87; 15%) than in those without (70/149; 47%) and varied with age, being lowest in patients under a year, of whom only 4/36 (11%) were confirmed. Measles specific IgM was detected in 71/77 (92%) of adequate saliva samples collected from patients with serum positive for IgM. In cases where measles was not confirmed, 6/101 had rubella specific IgM and 5/132 had human parvovirus B19 specific IgM detected in serum.
Conclusions : The existing national surveillance system for measles, which relies on clinically diagnosed cases, lacks the precision required for effective disease control. Saliva is a valid alternative to serum for IgM detection, and salivary diagnosis could play a major role in achieving measles elimination. Rubella and parvovirus B19 seem to be responsible for a minority of incorrectly diagnosed cases of measles in the United Kingdom and other infectious causes of measles-like illness need to be sought.
|
Public health implications
- Public health implications
- Disease surveillance is the cornerstone of programmes for measles control
- Surveillance based on clinically diagnosed measles cases is innaccurate - a clinical diagnosis of measles is confirmable by laboratory tests in only about one third of notified cases
- Of notified cases with a documented history of vaccination, 15% are confirmed as measles
- This study found agreement in detecting measles in 93% of paired serum and saliva samples; agreement was more likely if an adequate amount of saliva had been collected within 42 days of the onset of measles
- Salivary testing is a suitable non-invasive method for confirming clinical diagnosis of measles and could have an important role in controlling the disease
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Articles
-
Measles in the United Kingdom: can we eradicate it by 2010?
- Perviz Asaria and Eithne MacMahon
BMJ 2006 333: 890-895.
[Extract]
[Full Text]
[PDF]
-
Notifications of measles
- L L Lighton and L Greenwood
BMJ 1994 308: 1511.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Mbabazi, W. B, Nanyunja, M., Makumbi, I., Braka, F., Baliraine, F. N, Kisakye, A., Bwogi, J., Mugyenyi, P., Kabwongera, E., Lewis, R. F
(2009). Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda. Health Policy Plan
24: 261-269
[Abstract]
[Full text]
-
Abernathy, E., Cabezas, C., Sun, H., Zheng, Q., Chen, M.-h., Castillo-Solorzano, C., Ortiz, A. C., Osores, F., Oliveira, L., Whittembury, A., Andrus, J. K., Helfand, R. F., Icenogle, J.
(2009). Confirmation of Rubella within 4 Days of Rash Onset: Comparison of Rubella Virus RNA Detection in Oral Fluid with Immunoglobulin M Detection in Serum or Oral Fluid. J. Clin. Microbiol.
47: 182-188
[Abstract]
[Full text]
-
Asaria, P., MacMahon, E.
(2006). Measles in the United Kingdom: can we eradicate it by 2010?. BMJ
333: 890-895
[Full text]
-
Chibo, D., Riddell, M. A., Catton, M. G., Birch, C. J.
(2005). Applicability of Oral Fluid Collected onto Filter Paper for Detection and Genetic Characterization of Measles Virus Strains. J. Clin. Microbiol.
43: 3145-3149
[Abstract]
[Full text]
-
Moe, C. L., Sair, A., Lindesmith, L., Estes, M. K., Jaykus, L.-A.
(2004). Diagnosis of Norwalk Virus Infection by Indirect Enzyme Immunoassay Detection of Salivary Antibodies to Recombinant Norwalk Virus Antigen. CVI
11: 1028-1034
[Abstract]
[Full text]
-
Morris-Cunnington, M. C., Edmunds, W. J., Miller, E., Brown, D. W. G.
(2004). A Population-based Seroprevalence Study of Hepatitis A Virus Using Oral Fluid in England and Wales. Am J Epidemiol
159: 786-794
[Abstract]
[Full text]
-
Gibbs, S., Surridge, H., Adamson, R., Cohen, B., Bentham, G., Reading, R.
(2004). Atopic dermatitis and the hygiene hypothesis: a case-control study. Int J Epidemiol
33: 199-207
[Abstract]
[Full text]
-
Vyse, A. J., Gay, N. J., White, J. M., Ramsay, M. E., Brown, D. W. G., Cohen, B. J., Hesketh, L. M., Morgan-Capner, P., Miller, E.
(2002). Evolution of Surveillance of Measles, Mumps, and Rubella in England and Wales: Providing the Platform for Evidence-based Vaccination Policy. Epidemiol Rev
24: 125-136
[Full text]
-
Uzicanin, A., Eggers, R., Webb, E., Harris, B., Durrheim, D., Ogunbanjo, G., Isaacs, V., Hawkridge, A., Biellik, R., Strebel, P.
(2002). Impact of the 1996-1997 supplementary measles vaccination campaigns in South Africa. Int J Epidemiol
31: 968-976
[Abstract]
[Full text]
-
Ramsay, M, Reacher, M, O'Flynn, C, Buttery, R, Hadden, F, Cohen, B, Knowles, W, Wreghitt, T, Brown, D
(2002). Causes of morbilliform rash in a highly immunised English population. Arch. Dis. Child.
87: 202-206
[Abstract]
[Full text]
-
Kaufman, E., Lamster, I. B.
(2002). THE DIAGNOSTIC APPLICATIONS OF SALIVA-- A REVIEW. CROBM
13: 197-212
[Abstract]
[Full text]
-
Hofman, L. F.
(2001). Human Saliva as a Diagnostic Specimen. J. Nutr.
131: 1621S-1625
[Abstract]
[Full text]
-
Ward, K. N., Turner, D. J., Parada, X. C., Thiruchelvam, A. D.
(2001). Use of Immunoglobulin G Antibody Avidity for Differentiation of Primary Human Herpesvirus 6 and 7 Infections. J. Clin. Microbiol.
39: 959-963
[Abstract]
[Full text]
-
Vyse, A. J., Brown, D. W. G., Cohen, B. J., Samuel, R., Nokes, D. J.
(1999). Detection of Rubella Virus-Specific Immunoglobulin G in Saliva by an Amplification-Based Enzyme-Linked Immunosorbent Assay Using Monoclonal Antibody to Fluorescein Isothiocyanate. J. Clin. Microbiol.
37: 391-395
[Abstract]
[Full text]
-
Ryall, L., Goodbourn, C., Taylor, A., Teare, L.
(1996). Laboratories should use serum IgM tests to confirm measles. BMJ
312: 975c-976
[Full text]
-
Tait, D. R, Ward, K. N, Brown, D. W G, Miller, E.
(1996). Measles and rubella misdiagnosed in infants as exanthem subitum (roseola infantum). BMJ
312: 101-102
[Full text]
-
Ramsay, M., Brown, D.
(1995). Measles data are reliable. BMJ
311: 810-810
[Full text]
-
Roberts, R. J, Sandifer, Q. D, Evans, M. R, Nolan-Farrell, M. Z, Davis, P. M
(1995). Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine. BMJ
310: 1629-1639
[Abstract]
[Full text]
-
Miller, E
(1994). The new measles campaign. BMJ
309: 1102-1103
[Full text]
-
Lighton, L L, Greenwood, L
(1994). Notifications of measles. BMJ
308: 1511-1511
[Full text]